Crossmark

In vitro synergistic effect and mutant prevention concentration of eravacycline alone or in combination with various antibiotics against OXA-48 producing enterobacterales

Crossref DOI link: https://doi.org/10.1038/s41429-025-00823-w

Published Online: 2025-05-07

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Özer, Bekir

Mataraci Kara, Emel

Özbek Çelik, Berna
Funding

Funding for this research was provided by:

This work was supported by a grant from the Research Fund of the University of Istanbul (Istanbul, Turkey).

Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi (Project number: 35139)
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 15 August 2024

Revised: 14 March 2025

Accepted: 14 April 2025

First Online: 7 May 2025

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below